Dr. Peter Rubin
Claim this profileMaineHealth/SMHC Cancer Care and Blood Disorders-Biddeford
Studies Cancer
Studies Non-Small Cell Lung Cancer
17 reported clinical trials
42 drugs studied
Area of expertise
1Cancer
Stage IV
Stage III
Stage II
2Non-Small Cell Lung Cancer
Stage II
Stage III
Stage I
Affiliated Hospitals
Clinical Trials Peter Rubin is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Peter Rubin
Clinical Trial Related5 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Peter Rubin has experience with
- Atezolizumab
- Paclitaxel
- Pembrolizumab
- Gemcitabine Hydrochloride
- Pemetrexed Disodium
- Carboplatin
Breakdown of trials Peter Rubin has run
Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Colorectal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Peter Rubin specialize in?
Peter Rubin focuses on Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Peter Rubin currently recruiting for clinical trials?
Yes, Peter Rubin is currently recruiting for 7 clinical trials in Biddeford Maine. If you're interested in participating, you should apply.
Are there any treatments that Peter Rubin has studied deeply?
Yes, Peter Rubin has studied treatments such as Atezolizumab, Paclitaxel, Pembrolizumab.
What is the best way to schedule an appointment with Peter Rubin?
Apply for one of the trials that Peter Rubin is conducting.
What is the office address of Peter Rubin?
The office of Peter Rubin is located at: MaineHealth/SMHC Cancer Care and Blood Disorders-Biddeford, Biddeford, Maine 04005 United States. This is the address for their practice at the MaineHealth/SMHC Cancer Care and Blood Disorders-Biddeford.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.